Switch to:
More From Other Websites
EU offers benefits of "orphan" disease status to Ebola drugs Oct 20 2014
Ebola outbreak: Cashing in on a cure Oct 20 2014
A Promising Experimental Ebola Drug Goes Overlooked Oct 20 2014
Sarepta Therapeutics Shares Up On Ebola Drug Safety Study Oct 17 2014
Ahead of the Bell: Sarepta Therapeutics climbs Oct 17 2014
Ahead of the Bell: Sarepta Therapeutics climbs Oct 17 2014
Sarepta Is Surging After Good News For Its Ebola Treatment Oct 17 2014
[$$] Sarepta's Ebola Drug Showed No Ill Effects in Study Oct 16 2014
Sarepta says its Ebola drug has no ill effects Oct 16 2014
Sarepta Therapeutics Announces Publication of Ebola and Marburg Phase I Clinical Study Results in... Oct 16 2014
After-hours buzz: Google, SanDisk, Xilinx & more Oct 16 2014
Sarepta says it sees no side effects from Ebola drug Oct 16 2014
Sarepta Therapeutics Announces Publication of Ebola and Marburg Phase I Clinical Study Results in... Oct 16 2014
Volatility at its finest Oct 15 2014
[video] Funding pandemic preparedness Oct 13 2014
[video] CDC: Won't block West African flights Oct 13 2014
Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study Oct 13 2014
[video] Questioning Ebola protocols Oct 13 2014
Questioning Ebola protocols Oct 13 2014
[video] US nurses properly trained for Ebola? Oct 13 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK